국가: 영국
언어: 영어
출처: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ferrous fumarate
DE Pharmaceuticals
B03AA02
Ferrous fumarate
322mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010101
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT FERROUS FUMARATE 322MG FILM-COATED TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Ferrous Fumarate 322mg Film-Coated Tablets. It will be referred to as Ferrous Fumarate Tablets for ease hereafter. WHAT IS IN THIS LEAFLET 1. What Ferrous Fumarate Tablets are and what they are used for 2. What you need to know before you take Ferrous Fumarate Tablets 3. How to take Ferrous Fumarate Tablets 4. Possible side effects 5. How to store Ferrous Fumarate Tablets 6. Contents of the pack and other information 1. WHAT FERROUS FUMARATE TABLETS ARE AND WHAT THEY ARE USED FOR Ferrous Fumarate Tablets contain a form of iron called ferrous fumarate. Iron is usually found in foods and is necessary for the normal development of red blood cells. A lack of iron affects the development of the red blood cells and causes iron deficiency anaemia. Ferrous Fumarate Tablets are used to prevent or treat iron deficiency anaemia. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERROUS FUMARATE TABLETS DO NOT TAKE FERROUS FUMARATE TABLETS IF • You are allergic to Ferrous fumarate or any of the other ingredients of this medicine (listed in section 6), or to any other medicine containing iron • You have noticed blood in your urine • You suffer from any form of anaemia, other than iron deficiency anaemia, or from any other condition where your body’s iron is affected (your doctor will be able to advise you) • You have bronze markings on your skin or you have been told that you 전체 문서 읽기
OBJECT 1 FERROUS FUMARATE 322MG TABLETS Summary of Product Characteristics Updated 10-Oct-2019 | ADVANZ Pharma • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Fersaday 322mg Tablets Ferrous Fumarate 322mg Film-Coated Tablets 2. Qualitative and quantitative composition Each tablet contains 322.0mg Ferrous Fumarate BP (equivalent to approximately 100 mg ferrous iron) For the full list of excipients, see section 6.1 3. Pharmaceutical form Film-coated Tablets Each film coated tablet is brown ochre in colour and engraved 'FE' on one face and '322' on the other. 4. Clinical particulars 4.1 Therapeutic indications Prophylaxis and treatment of iron deficiency states. 4.2 Posology and method of administration Posology Adults and the elderly: One tablet daily (the foil enclosing the tablet is printed with days of the week in sequence). In severe or refractory iron deficiency, one tablet may be given twice a day. _Paediatric population:_ Ferrous Fumarate tablets are not intended fo 전체 문서 읽기